Fiduciary Family Office’s Thermo Fisher Scientific TMO Stock Holding History

Fiduciary Family Office’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$720K	Buy	1,465 +194	+15%	+$105K	0.21%	90
2025 Q4	$737K	Sell	1,271 -3	-0.2%	-$1.7K	0.21%	84
2025 Q3	$618K	Buy	1,274 +259	+26%	+$121K	0.18%	111
2025 Q2	$412K	Buy	1,015 +88	+9%	+$36.8K	0.13%	133
2025 Q1	$461K	Buy	+927	New	+$502K	0.15%	129
2024 Q4	–	Sell	-1,594	Closed	-$986K	–	231
2024 Q3	$986K	Buy	1,594 +38	+2%	+$22.5K	0.33%	66
2024 Q2	$860K	Sell	1,556 -186	-11%	-$107K	0.34%	75
2024 Q1	$1.01M	Buy	1,742 +282	+19%	+$158K	0.4%	65
2023 Q4	$775K	Buy	+1,460	New	+$707K	0.34%	63

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fiduciary Family Office's TMO Position: Q1 2026 in Review

Fiduciary Family Office increased its Thermo Fisher Scientific (TMO) stake by 15% in Q1 2026, buying an estimated $105K and bringing the position to 1,465 shares worth $720K. The position accounts for 0.21% of the portfolio, ranked #90.

Fiduciary Family Office first reported a position in TMO in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.01M in Q1 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Fiduciary Family Office held 1,465 shares of Thermo Fisher Scientific worth $720K as of Q1 2026.
Fiduciary Family Office bought 194 Thermo Fisher Scientific shares in Q1 2026, an estimated $105K.
Thermo Fisher Scientific made up 0.21% of Fiduciary Family Office's portfolio in Q1 2026, its #90 holding.
Fiduciary Family Office first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 9 quarters since.
Fiduciary Family Office's Thermo Fisher Scientific position peaked at $1.01M in Q1 2024.
2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fiduciary Family Office's 13F filing for Q1 2026, filed 14 May 2026.